Because primers can anneal at complementary sites distributed across RNA molecules, reverse transcriptase can initiate synthesis from more than one location on the available templates. This produces a collection of cDNA fragments representing different parts of the RNA population. The resulting coverage is broader than an approach centered on one transcript-specific starting site, supporting analysis of diverse expressed sequences.
Random Priming is useful when the goal is to represent many RNA molecules rather than selectively copy one known transcript. A transcript-specific primer focuses synthesis on its matching target, whereas multiple random primers can generate cDNA from varied templates in the sample. This distinction makes the technique suitable for broad expression studies and discovery-oriented analyses.
Highly abundant RNA molecules may contribute disproportionately to the resulting cDNA population because more template molecules are available for primer annealing and extension. Consequently, broad priming does not guarantee equal representation of every transcript. When interpreting expression profiles, investigators should consider whether dominant RNA species could influence the apparent distribution of sequences.
Degradation changes the available RNA template into shorter or incomplete molecules, which can alter where primers anneal and which regions become represented in cDNA. Although random priming can initiate synthesis across the remaining template, the resulting fragments may not reflect the original transcript population evenly. This condition is therefore important when assessing coverage and comparing expression results.
The workflow begins with RNA templates and random oligonucleotide primers, allowing the primers to anneal at complementary sites across the molecules. Reverse transcriptase then extends the annealed primers to produce cDNA fragments. That cDNA can subsequently support transcriptome profiling, reverse transcription quantitative PCR, or RNA sequencing, depending on the study’s analytical objective.
Cancer researchers can apply the technique when they need broad gene-expression information from tumors or cancer model systems. The resulting cDNA supports transcriptome profiling, reverse transcription quantitative PCR, and RNA sequencing. These applications can help examine diverse expressed transcripts across cancer-related samples, while interpretation should account for representation changes caused by RNA abundance or degradation.